TORONTO _ Ontario prioritizes elderly, unvaccinated residents and immunosuppressed individuals for a new antiviral COVID-19 treatment.
The province received its first consignment of Paxlovid last week, and Health Minister Christine Elliott said the drug would target adults at greatest risk.
Ontario has now released its guidelines for who is eligible for treatment, including immunosuppressed adults, unvaccinated people 60 and older, and unvaccinated people 50 and older if they have one or more risk factors, or First Nation, Inuit or Metis individuals is.
Ottawa prepares for ‘significant’ convoy disruptions of truck drivers as police warn of risks
Spotify takes down Neil Young’s music following his Joe Rogan ultimatum
Ontario will receive 10,000 courses of Pfizer’s Paxlovid COVID-19 pill in January
The treatment, which is currently available in limited quantities, will be available at clinical assessment centers across the province, although not all 75 centers will necessarily have the antiviral drugs on hand.
People who would qualify for Paxlovid must first test positive for COVID-19, and the province says qualifying individuals can receive either a PCR test or a rapid test at those sites.
Treatment with Paxlovid – six pills a day for five days – should start to be effective within five days of the onset of symptoms.
View link »
© 2022 The Canadian Press